Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576. doi:10.1053/j.gastro.2007.04.06117570226
   PubMed Web of Science ®Google Scholar
• Peng W, Li C, Zhu WJ, et al. Prognostic value of the platelet to lymphocyte ratio change in liver cancer. J Surg Res. 2015;194(2):464–470. doi:10.1016/j.jss.2014.12.02125577142
   PubMed Web of Science ®Google Scholar
• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–851. doi:10.1016/S0140-6736(08)60383-918328931
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice guidelines committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236.16250051
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The L, European Organisation For R, treatment of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943.22424438
   PubMed Web of Science ®Google Scholar
• Vogel A, Cervantes A, Chau I, et al. Correction to: “hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up”. Ann Oncol. 2019;30(5):871–873. doi:10.1093/annonc/mdy510
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429–442. doi:10.1053/jhep.2003.5004712540794
   PubMed Web of Science ®Google Scholar
• Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32(4):348–359. doi:10.1055/s-0032-132990623397536
   PubMed Web of Science ®Google Scholar
• Piscaglia F, Ogasawara S. Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit/risk assessment. Liver Cancer. 2018;7(1):104–119. doi:10.1159/00048547129662837
   PubMed Web of Science ®Google Scholar
• Kabir T, Ye M, Mohd Noor NA, Woon W, Junnarkar SP, Shelat VG. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes after curative resection for hepatocellular carcinoma. Int J Hepatol. 2019;2019:4239463. doi:10.1155/2019/423946331065387
   PubMed Web of Science ®Google Scholar
• Ji F, Fu SJ, Shen SL, et al. The prognostic value of combined TGF-beta1 and ELF in hepatocellular carcinoma. BMC Cancer. 2015;15:116. doi:10.1186/s12885-015-1127-y25880619
   PubMed Web of Science ®Google Scholar
• Fu SJ, Qi CY, Xiao WK, Li SQ, Peng BG, Liang LJ. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection. Surgery. 2013;154(3):536–544. doi:10.1016/j.surg.2013.02.01423601901
   PubMed Web of Science ®Google Scholar
• Kim DY, Paik YH, Ahn SH, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology. 2007;72(Suppl 1):52–57. doi:10.1159/00011170718087182
   PubMed Web of Science ®Google Scholar
• Du XJ, Tang LL, Mao YP, et al. Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma. J Transl Med. 2015;13:364. doi:10.1186/s12967-015-0729-026585371
   PubMed Web of Science ®Google Scholar
• Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37(11):2688–2692. doi:10.1007/s00268-013-2156-923884382
   PubMed Web of Science ®Google Scholar
• Lee DY, Hong SW, Chang YG, Lee WY, Lee B. Clinical significance of preoperative inflammatory parameters in gastric cancer patients. J Gastric Cancer. 2013;13(2):111–116. doi:10.5230/jgc.2013.13.2.11123844326
   PubMedGoogle Scholar
• He CB, Lin XJ. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PLoS One. 2017;12(3):e0174769. doi:10.1371/journal.pone.017476928355305
   PubMed Web of Science ®Google Scholar
• Huang Z-L, Luo J, Chen M-S, Li J-Q, Shi M. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. J Vasc Interv Radiol. 2011;22(5):702–709. doi:10.1016/j.jvir.2010.12.04121514523
   PubMed Web of Science ®Google Scholar
• Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106(8):1439–1445. doi:10.1038/bjc.2012.9222433965
   PubMed Web of Science ®Google Scholar
• Yamamura K, Sugimoto H, Kanda M, et al. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci. 2014;21(9):682–688. doi:10.1002/jhbp.11424823966
   PubMed Web of Science ®Google Scholar
• Liu C, Li L, Lu WS, et al. Neutrophil-lymphocyte ratio plus prognostic nutritional index predicts the outcomes of patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Sci Rep. 2017;7(1):13873. doi:10.1038/s41598-017-13239-w29066730
   PubMed Web of Science ®Google Scholar
• Ni XC, Yi Y, Fu YP, et al. Prognostic value of the modified Glasgow prognostic score in patients undergoing radical surgery for hepatocellular carcinoma. Medicine. 2015;94(36):e1486. doi:10.1097/MD.000000000000148626356714
   PubMed Web of Science ®Google Scholar
• Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-314726171
   PubMed Web of Science ®Google Scholar
• Schutte K, Tippelt B, Schulz C, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr. 2015;34(6):1122–1127. doi:10.1016/j.clnu.2014.11.00725434576
   PubMed Web of Science ®Google Scholar
• Okamura Y, Maeda A, Matsunaga K, Kanemoto H, Uesaka K. Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012;19(4):449–457. doi:10.1007/s00534-011-0461-y21983894
   PubMed Web of Science ®Google Scholar
• Ji F, Liang Y, Fu S, et al. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy. HPB (Oxford). 2017;19(8):695–705. doi:10.1016/j.hpb.2017.04.00828479010
   PubMed Web of Science ®Google Scholar
• Souza Cunha M, Wiegert EVM, Calixto-Lima L, Oliveira LC. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care. Nutrition. 2018;51–52:98–103. doi:10.1016/j.nut.2017.12.004
   PubMed Web of Science ®Google Scholar
• Rahman R, Hammoud GM, Almashhrawi AA, Ahmed KT, Ibdah JA. Primary hepatocellular carcinoma and metabolic syndrome: an update. World J Gastrointest Oncol. 2013;5(9):186–194. doi:10.4251/wjgo.v5.i9.18624069511
   PubMed Web of Science ®Google Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–226. doi:10.1097/MCO.0b013e32832a790219318937
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. doi:10.1093/carcin/bgp12719468060
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum. 2015;58(11):1048–1057. doi:10.1097/DCR.000000000000045826445177
   PubMed Web of Science ®Google Scholar
• Hong S, Zhou T, Fang W, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol. 2015;36(5):3389–3397. doi:10.1007/s13277-014-2973-y25527156
   PubMedGoogle Scholar
• Chan AW, Chan SL, Wong GL, et al. Prognostic Nutritional Index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22(13):4138–4148. doi:10.1245/s10434-015-4516-125801356
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Onoda H, Imai N, et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer. 2012;107(6):988–993. doi:10.1038/bjc.2012.35422878374
   PubMed Web of Science ®Google Scholar